Chord Energy Corporation
CHRD
$140.84
-5.58%
Chord Energy Corporation is an independent exploration and production (E&P) company focused on the acquisition, development, and production of crude oil, natural gas liquids (NGL), and natural gas, with its primary operations concentrated in the Williston Basin and limited non-operated interests in the Marcellus Shale. The company operates as a pure-play, mid-cap E&P firm, distinguished by its operational focus on a premier U.S. onshore basin and a strategy emphasizing capital discipline and shareholder returns. The current investor narrative is heavily influenced by volatile oil prices and shifting geopolitical risk premiums, as recent news of de-escalation in the Middle East and the reopening of the Strait of Hormuz has triggered a sharp decline in crude prices, directly impacting the revenue outlook and stock performance of oil producers like Chord Energy.…
CHRD
Chord Energy Corporation
$140.84
Investment Opinion: Should I buy CHRD Today?
Rating: Hold. The core thesis is that CHRD is a well-managed E&P company caught in a deteriorating fundamental environment, where near-term oil price headwinds offset its strong operational and financial positioning, resulting in a balanced risk/reward at current levels.
Supporting this Hold rating are several data points: the reasonable forward P/E of 9.84x (vs. a nonsensical trailing 120.54x), the robust TTM free cash flow of $713.5 million, the fortress balance sheet (D/E 0.19), and the 5.93% dividend yield which provides some downside cushion. However, these positives are counterbalanced by the severe Q4 margin collapse (gross margin from 30.7% to 10.37%) and the direct threat from the recent 14% oil price crash, which jeopardizes the forward EPS estimates of $13.14 that the valuation relies upon.
The two biggest risks that could invalidate this thesis are 1) WTI oil prices sustaining below a level that makes Williston Basin production uneconomic, leading to further margin erosion, and 2) the company missing the forward EPS estimate, triggering a derating from the current forward multiple. This Hold would upgrade to a Buy if the forward P/E compressed below 8x without a deterioration in the long-term oil price outlook, or if gross margins demonstrated resilience above 15% in the next quarter despite lower oil. It would downgrade to a Sell if revenue growth turned negative sequentially and forward EPS estimates were cut by more than 15%. On valuation, the stock is fairly valued relative to its forward earnings potential but overvalued relative to its current, depressed profitability.
Sign up to view all
CHRD 12-Month Price Forecast
CHRD presents a classic 'good company, bad timing' scenario. Its strong balance sheet, cash flow, and shareholder returns are laudable, but these are currently overshadowed by the acute, externally-driven risk of lower oil prices crushing its near-term profitability. The market is correctly valuing it on future earnings (forward P/E 9.84x), but those future earnings are now under direct threat. The neutral stance reflects this balance. The stance would upgrade to bullish on evidence of operational margin resilience in the face of lower oil prices or a technical breakout above $150 on sustained volume. It would turn bearish if the stock breaks below its 200-day moving average (not provided, but inferred from price action) on high volume or if the next quarterly report shows further gross margin deterioration.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Chord Energy Corporation's 12-month outlook, with a consensus price target around $183.09 and implied upside of +30.0% versus the current price.
Average Target
$183.09
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$113 - $183
Analyst target range
Analyst coverage for Chord Energy is limited, with only 2 analysts providing estimates, indicating this is a smaller-cap E&P name with less institutional following, which can contribute to higher volatility and less efficient price discovery. The average revenue estimate for the coming period is $4.68 billion, with a wide range from $4.20 billion to $5.24 billion, and the average EPS estimate is $13.14, ranging from $11.38 to $15.18; this wide dispersion in targets reflects significant uncertainty around commodity price realizations and operational performance. Recent institutional ratings from firms like Morgan Stanley, Wells Fargo, and Piper Sandler have been consistently bullish, with actions like 'Overweight' and 'Buy' reaffirmed throughout Q1 2026, suggesting professional sentiment remains positive on the company's strategy and asset base despite near-term oil price headwinds.
Bulls vs Bears: CHRD Investment Factors
The bull case for CHRD is anchored in its strong technical momentum, reasonable forward valuation, robust balance sheet, and shareholder-friendly capital return policy. The bear case is equally compelling, highlighting the company's extreme sensitivity to crashing oil prices, severe recent margin compression, and an unsustainable trailing valuation. Currently, the bearish evidence holds stronger weight because the fundamental driver of the stock—oil prices—has turned sharply negative, directly threatening the earnings recovery that the entire forward valuation rests upon. The single most important tension in the investment debate is whether CHRD's operational discipline and cost structure can preserve sufficient profitability to meet the market's high forward earnings expectations ($13.14 EPS) in the face of a potentially sustained lower oil price environment.
Bullish
- Strong Technical Momentum: The stock is in a powerful uptrend, up 57.54% over the past year and 59.90% over six months, trading at 98% of its 52-week high. This momentum is supported by a low beta of 0.532, indicating the rally has been less volatile than the market, suggesting steady accumulation.
- Attractive Forward Valuation: The forward P/E of 9.84x, based on estimated EPS of $13.14, is reasonable for an E&P company and suggests significant earnings recovery is priced in. The stock also trades at a discount to sector averages on key metrics like EV/EBITDA (3.72x) and Price-to-Sales (1.10x).
- The company generated $713.5 million in TTM free cash flow and maintains a strong, conservatively leveraged balance sheet with a debt-to-equity ratio of 0.19. This provides a substantial cushion for capital returns and navigating commodity price volatility.
- Positive Analyst Sentiment: Despite limited coverage (2 analysts), institutional ratings from firms like Morgan Stanley and Wells Fargo have been consistently bullish (Overweight/Buy). The average EPS estimate of $13.14 implies strong forward earnings power, with a high-end target of $15.18.
Bearish
- Extreme Commodity Price Sensitivity: Recent news of the Strait of Hormuz reopening triggered a 14% crash in crude oil, directly impacting CHRD's revenue model. Q4 2025 revenue declined 19.6% YoY to $1.17 billion, demonstrating severe vulnerability to geopolitical and macro-driven oil price swings.
- Severe & Recent Margin Compression: Gross margin collapsed from 30.7% in Q1 2025 to 10.37% in Q4 2025, and the full-year net margin is a thin 0.91%. This dramatic compression, if sustained due to lower oil prices, threatens the earnings recovery priced into the forward P/E.
- Extreme Trailing Valuation: The trailing P/E of 120.54x is astronomically high and near the extreme end of the stock's historical range, driven by a depressed annualized EPS of $0.0083. This indicates the stock's current price is entirely dependent on a swift and substantial earnings rebound.
- Limited Analyst Coverage & High Short Interest: With only 2 analysts providing estimates, price discovery is less efficient and the stock may be prone to higher volatility. A short ratio of 2.57 indicates a significant portion of the market is betting against the stock's near-term prospects.
CHRD Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 1-year price change of +57.54% and a 6-month gain of +59.90%. As of the latest close at $145.06, the price is trading near the top of its 52-week range, approximately 98% of the way from its 52-week low of $84.25 toward its high of $148.42, indicating strong momentum but also positioning the stock at levels vulnerable to a pullback or consolidation. Recent momentum shows acceleration, with a 3-month price surge of +44.71% and a 1-month gain of +5.91%, although the 1-month performance has notably underperformed the S&P 500's +9.98% gain, resulting in a negative 1-month relative strength of -4.07, suggesting the stock may be taking a breather after its massive run. Key technical support is anchored at the 52-week low of $84.25, while immediate resistance sits at the 52-week high of $148.42; a decisive breakout above this level could signal a continuation of the bullish trend, while a failure could lead to a test of lower support. The stock's beta of 0.532 indicates it has been significantly less volatile than the broader market during this period, which is atypical for an energy E&P stock and may reflect its specific operational profile or investor base.
Beta
0.40
0.40x market volatility
Max Drawdown
-27.8%
Largest decline past year
52-Week Range
$84-$151
Price range past year
Annual Return
+55.4%
Cumulative gain past year
| Period | CHRD Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | +11.4% |
| 3m | +43.0% | +8.3% |
| 6m | +61.1% | +9.4% |
| 1y | +55.4% | +31.3% |
| ytd | +48.8% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHRD Fundamental Analysis
Revenue trajectory has been volatile and recently declined, with Q4 2025 revenue of $1.17 billion representing a -19.6% year-over-year contraction, following a sequential drop from Q3's $1.31 billion; this underscores the company's direct sensitivity to commodity price swings, as seen in the recent oil price crash. Profitability remains positive but compressed, with Q4 net income of $84.4 million and a gross margin of 10.37%, a significant decline from the 30.7% gross margin in Q1 2025, highlighting severe margin pressure in the latter part of the year; the full-year net margin stands at a thin 0.91%. The balance sheet is conservatively leveraged with a debt-to-equity ratio of 0.19, and the company generates substantial cash, evidenced by trailing twelve-month free cash flow of $713.5 million and a current ratio of 1.06, providing a solid financial cushion to navigate commodity cycles and fund its capital return program.
Quarterly Revenue
$1.2B
2025-12
Revenue YoY Growth
-0.19%
YoY Comparison
Gross Margin
+0.10%
Latest Quarter
Free Cash Flow
$713497000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHRD Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is elevated at 120.54x, heavily influenced by the low annualized EPS of $0.0083, while the forward PE is a much more reasonable 9.84x, based on estimated EPS of $13.14; this massive gap implies the market is pricing in a significant earnings recovery and normalization from the depressed Q4 2025 results. Compared to sector averages, Chord trades at a discount on a Price-to-Sales basis (PS ratio of 1.10) and on an EV/EBITDA basis (3.72x), which are more relevant for cyclical E&P firms; these discounts may reflect concerns over near-term margin compression or its specific asset base relative to peers. Historically, the stock's current trailing PE of 120.54x is near the extreme high end of its own range over the past several years, which typically saw PEs between single digits and the mid-teens during profitable periods; this extreme multiple signals the market is currently valuing the stock based on anticipated future earnings power rather than trailing results, embedding high expectations for a rebound.
PE
120.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -7x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
3.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on extreme earnings volatility and margin pressure. Q4 2025 gross margin of 10.37% represents a catastrophic drop from 30.7% just three quarters prior, and the full-year net margin of 0.91% offers minimal buffer. Revenue is 100% tied to volatile commodity prices, as evidenced by the 19.6% YoY decline in Q4. While the balance sheet is strong (D/E 0.19), the company's valuation (120.54x trailing P/E) is entirely dependent on a swift earnings recovery; failure to achieve the $13.14 forward EPS estimate would trigger severe multiple compression.
Market & Competitive Risks are dominated by oil price exposure and valuation compression. The recent 14% crude crash on Middle East de-escalation news is a direct and immediate threat to CHRD's revenue and margin outlook. Trading at a forward P/E of 9.84x, the stock appears cheap, but this is a cyclical value trap if oil prices remain depressed—the sector-average discount on EV/EBITDA (3.72x) could quickly vanish. The stock's low beta of 0.532 is deceptive; it reflects past stability during an uptrend but may not hold in a sustained oil bear market, exposing investors to sector-wide outflows.
Worst-Case Scenario involves a prolonged period of subdued oil prices, perhaps due to geopolitical peace and economic slowdown, leading to consecutive quarters of margin compression and earnings misses. This would shatter the forward earnings narrative, causing analyst downgrades and a flight from the stock. The realistic downside could see the stock re-test its 52-week low of $84.25, representing a potential loss of approximately -42% from the current price of $145.06. A drawdown of this magnitude is plausible given the stock's historical max drawdown of -27.75% and the severe fundamental shock of lower-for-longer oil.
FAQ
The key risks, in order of severity, are: 1) Commodity Price Risk: Revenue is 100% exposed to oil & gas prices, which just crashed 14% on geopolitical news. 2) Margin Compression Risk: Gross margins collapsed from 30.7% to 10.37% in 2025; further erosion would crush earnings. 3) Valuation Risk: The entire investment case rests on achieving a forward EPS of $13.14; any shortfall could cause the reasonable forward P/E to expand rapidly. 4) Liquidity & Sentiment Risk: With only 2 analyst estimates, the stock has less institutional support and price discovery, which can exacerbate moves driven by sector-wide sentiment shifts.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $130 and $148, assuming oil prices range-bound and CHRD meets the average EPS estimate of $13.14. The Bull Case (25% probability) targets $148 to $175, driven by rebounding oil prices and earnings beats. The Bear Case (25% probability) warns of a drop to $84-$110 if low oil prices persist and margins deteriorate further. The Base Case is most likely, but its key assumption—stable oil prices allowing earnings recovery—is currently under threat from recent market developments.
CHRD's valuation is a tale of two metrics, leading to a mixed picture. It is dramatically overvalued on a trailing basis, with a P/E of 120.54x due to depressed recent earnings. However, it appears fairly valued to slightly undervalued on a forward basis, with a P/E of 9.84x based on expected EPS recovery. Compared to sector peers, it trades at a discount on Price-to-Sales (1.10x) and EV/EBITDA (3.72x). The forward multiple implies the market expects a significant earnings normalization. Therefore, the stock is fairly valued relative to future potential but carries high execution risk to achieve that potential.
CHRD is a Hold, not a clear Buy at current levels. For investors already bullish on oil, it represents a reasonably-priced vehicle with a strong balance sheet and a 5.93% yield. The forward P/E of 9.84x offers value if the company meets its $13.14 EPS estimate. However, it is not a good buy for risk-averse investors or those with a short-term horizon, given the extreme sensitivity to volatile oil prices—evidenced by the recent 14% crude crash—and the stock's position near its 52-week high after a 57.54% rally. The biggest downside risk is a sustained drop in oil prices invalidating the earnings recovery thesis.
CHRD is more suitable for a medium-to-long-term investment horizon (2+ years) rather than short-term trading. As a pure-play E&P company, its fortunes are tied to the multi-year oil price cycle. The 5.93% dividend yield supports a total return approach for income-oriented investors. Its low beta of 0.532 is misleading for short-term traders, as the stock can experience sharp moves on oil news (as recently seen). The limited analyst coverage also reduces short-term informational efficiency. A long-term holder can benefit from the company's capital discipline and wait for the oil cycle to turn, while a short-term trader would be primarily betting on volatile oil price fluctuations.